Conjugated linoleic acid (CLA / Tonalin c9,t11 & t10,c12)
Conjugated Linoleic Acid (CLA / Tonalin) · also known as Conjugated linoleic acid, CLA, Tonalin, Linoleic acid isomers
Conjugated linoleic acid is a mixture of several isomers; c9,t11 is the main one in foods from ruminant animals. Human study results are inconsistent. Some studies suggest the t10,c12 isomer may increase oxidative stress and impair insulin sensitivity, and human evidence for fat loss is insufficient.
Clinical uses and human evidence
Body weight and body fat
Blood sugar and insulin resistance
Studies (2)
- Ghodoosi 2023 · Nutr J · Meta-analysis · n=723 — The effects of conjugated linoleic acid supplementation on glycemic control, adipokines, cytokines, malondialdehyde and liver function enzymes in patients at risk of cardiovascular disease: a GRADE-assessed systematic review and dose-response meta-analysis
- Liang 2023 · Nutr Rev · Meta-analysis — Effects of conjugated linoleic acid and exercise on body composition and obesity: a systematic review and meta-analysis
Muscle strength and mass
Studies (2)
- Asbaghi 2024 · Br J Nutr · Meta-analysis · n=4159 — The effects of conjugated linoleic acid supplementation on anthropometrics and body composition indices in adults: a systematic review and dose-response meta-analysis
- Liang 2023 · Nutr Rev · Meta-analysis — Effects of conjugated linoleic acid and exercise on body composition and obesity: a systematic review and meta-analysis
High LDL cholesterol
High triglycerides
Mechanisms of action
Acylcarnitine shuttle into mitochondria and β-oxidation
CLA is not a carnitine-like compound and does not take part directly in the acylcarnitine shuttle. In mice, carnitine palmitoyltransferase activity in muscle or fat tissue rose under some conditions. In a human crossover trial, 3.8 g/day of mixed CLA did not improve measured fat oxidation. The human evidence is inconsistent.
AMPK sensing of cellular energy deficit and metabolic reprogramming
Inhibition of lipoprotein lipase activity does not, by itself, show that AMPK is activated. AMPK-related effects are seen mainly in mouse and cell models and vary with isomer, tissue and dose. No reliable AMPK-specific marker has yet confirmed the effect in humans taking CLA orally.
Inhibition of NF-κB / AP-1, the master switches of pro-inflammatory transcription
In animal studies, CLA can downregulate NF-κB-related signaling under some conditions, but the direction of the inflammatory effect differs between isomers. Neither the claim that c9,t11 is a weak PPAR-γ agonist nor a fall in TNF-α is enough on its own to prove that NF-κB is inhibited in humans.